Creative Planning’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Creative Planning’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-111,953	Closed	-$11K	–	5082
2016 Q3	$11K	Buy	111,953 +33,135	+42%	+$7.23K	﹤0.01%	3486
2016 Q2	$29K	Hold	78,818	–	–	﹤0.01%	2536
2016 Q1	$30K	Sell	78,818 -3,000	-4%	-$1.24K	﹤0.01%	2474
2015 Q4	$32K	Buy	81,818 +3,000	+4%	+$1.42K	﹤0.01%	2494
2015 Q3	$45K	Sell	78,818 -33,000	-30%	-$16.9K	﹤0.01%	2125
2015 Q2	$60K	Buy	111,818 +21,418	+24%	+$17.5K	﹤0.01%	1024
2015 Q1	$74K	Buy	90,400 +15,000	+20%	+$12.4K	﹤0.01%	1752
2014 Q4	$60K	Buy	75,400 +26,500	+54%	+$24.2K	﹤0.01%	1889
2014 Q3	$50K	Buy	48,900 +17,500	+56%	+$17K	﹤0.01%	1936
2014 Q2	$27K	Buy	+31,400	New	+$37.6K	﹤0.01%	2315

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Creative Planning's PVCT Position: Q4 2016 in Review

Creative Planning sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 111,953 shares — an estimated $11K sold.

Creative Planning first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $74K in Q1 2015. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

Creative Planning reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
Creative Planning sold 111,953 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $11K.
Creative Planning first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
Creative Planning's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $74K in Q1 2015.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.